Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
Stewart Mearns MPS[/caption]
Case scenario
Greg, a 28-year-old man, comes into your pharmacy asking for a ‘strong minoxidil hair product’. He explains that his doctor recently diagnosed him with male pattern hair loss and suggested he try an over-the-counter treatment, with a follow-up review in 6 months. Greg has noticed gradual thinning at the temples over the past year but reports no sudden hair loss, scalp irritation or other medical issues. He has no known allergies, takes no medicines and has no chronic conditions.
Learning objectivesAfter reading this article, pharmacists should be able to:
Competency standards (2016) addressed: 1.1, 1.4, 1.5, 2.2, 3.1, 3.5 Accreditation number: CAP2602DMFK Accreditation expiry: 31/01/2029 |
Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.
Introduction
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
